Skip to main content
GutCited

Resistant Starch : Ulcerative Colitis (UC)

D 研究 予備的な研究(実験室研究、症例報告)のみが存在します。

Single pilot study showed resistant starch (40 g/day) increased fecal butyrate. Clinical remission endpoint not powered.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dresistant\u002Dstarch\u0026condition\u003Dibd\u002Dulcerative\u002Dcolitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

結論

Single pilot study showed resistant starch (40 g/day) increased fecal butyrate. Clinical remission endpoint not powered.

Key Study Findings

Review
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
Dose: None vs: None Outcome: None 効果: None None

対象集団: patients with ulcerative colitis

Review
Resistant starches and health.
Dose: Resistant starches vs: None Outcome: Colonic health, SCFA production 効果: None None

対象集団: General population

Other
Resistant starches.
Dose: None vs: None Outcome: lipid levels 効果: None None

対象集団: type 2 diabetes patients

Key Statistics

1

研究数

40

参加者数

↑

Positive

D

グレード

Referenced Papers

Journal of AOAC … 2004
Current opinion in … 2000 28 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
15-30 g/day
guthealthsupport:
20-40 g/day (titrate up gradually over 2-4 weeks)

上限量: Well-tolerated up to 45 g/day when titrated gradually

研究で検討された用量

用量 期間 効果 N
None -- Mixed --
Resistant starches -- Positive --
None -- Positive --

推奨摂取タイミング: With meals; start with small amount (5 g/day) and increase gradually

Safety & Side Effects

報告されている副作用

  • ⚠ Gas and bloating (common initially; typically resolves in 2-4 weeks)
  • ⚠ Flatulence (more pronounced than other prebiotics)
  • ⚠ Abdominal discomfort during adaptation period
  • ⚠ Loose stools if introduced too quickly

既知の相互作用

  • ● Blood sugar-lowering medications (resistant starch may improve insulin sensitivity)
  • ● Other high-fiber foods (cumulative fermentation effect)

耐容上限摂取量: Well-tolerated up to 45 g/day when titrated gradually

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Resistant Starch help with Ulcerative Colitis (UC)?
Based on 1 studies with 40 participants, there is preliminary evidence that needs more research that Resistant Starch may support Ulcerative Colitis (UC) management. Our evidence grade is D (Very Early Research).
How much Resistant Starch should I take for Ulcerative Colitis (UC)?
Studies have used various dosages. A commonly studied range is 15-30 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resistant Starch?
Reported side effects may include Gas and bloating (common initially; typically resolves in 2-4 weeks), Flatulence (more pronounced than other prebiotics), Abdominal discomfort during adaptation period, Loose stools if introduced too quickly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resistant Starch and Ulcerative Colitis (UC)?
We rate the evidence as Grade D (Very Early Research). This rating is based on 1 peer-reviewed studies with 40 total participants. The overall direction of effect is positive.

References

  1. [1] Fares Jamal et al.. Dig Dis Sci. 2026. Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment. doi:10.1007/s10620-025-09387-z PubMed
  2. [2] Cyril W C Kendall et al.. J AOAC Int. 2004. Resistant starches and health. PubMed
  3. [3] D J Jenkins et al.. Curr Opin Gastroenterol. 2000. Resistant starches. doi:10.1097/00001574-200003000-00014 PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。